#USA #Irving #Chief Commercial Officer #Longitude Rx #Stacy Walton

Longitude Rx Appoints Stacy Walton as Inaugural CCO

In a significant move aimed at bolstering its growth and enhancing partnerships, Longitude Rx has officially named Stacy Walton as its inaugural Chief Commercial Officer (CCO). This appointment, announced on March 31, 2026, signals the organization's commitment to improving access to specialty pharmacy services across health systems.

Walton brings over three decades of expertise in specialty pharmacy, payer strategies, and clinical operations, making her a valuable asset to Longitude Rx as it seeks to expand its market presence. Her role will encompass overseeing vital areas such as market access strategies, payer and manufacturer engagements, and the overall growth of health systems involved with Longitude Rx.

Jigar Thakkar, the Chief Executive Officer of Longitude Rx, expressed confidence in Walton’s capabilities. "Stacy brings exactly the combination of clinical credibility and commercial sophistication this role demands," he stated. He emphasized the need for a leader who can synchronize market access, payer strategies, and growth initiatives into a cohesive commercial engine, which Walton is expected to deliver.

A Vision for Improved Patient Access

As CCO, Walton aims to prioritize objectives that include increasing access to limited distribution drugs, bolstering payer networks, and optimizing the specialty pharmacy performance using AI-driven workflows. This approach is critical to ensuring that patients receive timely and efficient access to necessary therapies.

Walton's career began as a critical care registered nurse, where she quickly established a commendable track record within the specialty pharmacy and commercial strategy realms. Her previous role at OptumRx involved managing national clinical programs spanning various medical fields, including oncology and rare diseases. As Senior Director, she also handled contract negotiations and improved access to restricted drug networks, showcasing her strategic prowess.

Most recently, Walton served as Senior Vice President at a national firm focused on hospital-owned specialty pharmacy solutions, supporting over 80 health systems. Her vast experience equips her with the insights needed to navigate the complex healthcare landscape and establish strong partnerships.

Embracing Alternative Approaches

In her own words, Walton shared her motivation for joining Longitude Rx, stating, "Having spent my career at the intersection of clinical care and commercial strategy, I know firsthand how much is at stake when a patient can't access the therapy they need." She is committed to scaling the unique model that Longitude Rx offers, which is designed specifically for health systems, ensuring that more organizations and patients can benefit from its innovative services.

Longitude Rx was founded in 2024 as a health system-owned specialty pharmacy organization. With founding members including prominent healthcare providers that collectively represent over $60 billion in net patient service revenue, Longitude Rx aims to integrate all aspects of the specialty pharmacy journey, using a unified and data-driven platform. This structure is crucial for improving clinical and financial outcomes within the healthcare system.

The organization’s focus on building strong infrastructure that health systems can own and govern is a response to the critical healthcare challenges of providing access to comprehensive pharmacy services. By leveraging data and collaborative approaches, Longitude Rx is well-positioned to lead in the specialty pharmacy sector.

In conclusion, the onboarding of Stacy Walton as CCO heralds a new chapter for Longitude Rx as it strives to enhance its service offerings and reach more patients in need of specialized care. The vision of unifying market access and operational strategies under her leadership is expected to play a pivotal role in the organization's growth trajectory for years to come.